)
Company research29 Apr 2026
Target Corporation: The Business Behind the Bullseye
How Target grew from a Minneapolis dry goods store into a retail giant, blending discount pricing with design and private-label power.
Aldeyra Therapeutics
Aldeyra Therapeutics (ALDX) investor relations material
Aldeyra Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary27 Apr, 2026
Voting matters and shareholder proposals
Election of one Class III Director, with Todd C. Brady, M.D., Ph.D. nominated for the position.
Ratification of BDO USA, P.C. as the independent registered public accounting firm for the year ending December 31, 2026.
Advisory vote to approve the compensation of named executive officers.
Additional business may be addressed if properly brought before the meeting or any adjournment.
Board of directors and corporate governance
Board recommends voting in favor of all proposals presented at the annual meeting.
Executive compensation and say-on-pay
Shareholders are asked to approve, on a non-binding advisory basis, the compensation of named executive officers.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Aldeyra Therapeutics
- Proxy covers director election, auditor ratification, and say-on-pay, with strong governance focus.ALDX
Proxy filing27 Apr 2026 - Net loss decreased to $33.8M in 2025; FDA decision on reproxalap and AbbVie option remain key catalysts.ALDXQ4 202527 Feb 2026
- Reproxalap nears FDA decision, targeting rapid relief in dry eye and allergy with AbbVie partnership.ALDXOppenheimer 36th Annual Healthcare Life Sciences Conference25 Feb 2026
- RASP modulator pipeline advances with key milestones and strong financials for 2024–2025.ALDXStatus Update3 Feb 2026
- Reproxalap met its Phase 3 endpoint, enabling NDA resubmission and potential commercial partnership.ALDXStudy Update2 Feb 2026
- Late-stage dry eye trials, AbbVie partnership, and diverse pipeline drive near-term catalysts.ALDXJefferies 2024 Global Healthcare Conference1 Feb 2026
- NDA resubmission for rapid-acting dry eye therapy is imminent, with robust pipeline progress.ALDXH.C. Wainwright 26th Annual Global Investment Conference 202420 Jan 2026
- Lead drug for dry eye nears FDA decision, with AbbVie partnership and broad pipeline expansion.ALDXJefferies London Healthcare Conference 202412 Jan 2026
- Late-stage eye drug developers outlined novel therapies and 2024 launch milestones.ALDXCiti's 2024 Global Healthcare Conference11 Jan 2026
Next Aldeyra Therapeutics earnings date
Q1 20268 May, 2026
Aldeyra Therapeutics
Next Aldeyra Therapeutics earnings date
Q1 20268 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Business philosophy23 Apr 2026
Greg Foran: The New CEO of Kroger
How Greg Foran rose from store floor to CEO of Kroger, led Walmart's turnaround, and built a leadership style focused on execution.
)
Company research22 Apr 2026
Companies That Had Their IPO in 2025: The IPO Market Recovers
After years of uncertainty, 2025 marked the IPO market's return, with major listings like Klarna and Figma signaling renewed momentum.
Frequently asked questions
Explore our global coverage